##gff-version 3
##sequence-region Q8NC51 1 408
Q8NC51	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:25944712,ECO:0000269|Ref.8;Dbxref=PMID:25944712	
Q8NC51	UniProtKB	Chain	2	408	.	.	.	ID=PRO_0000058182;Note=Plasminogen activator inhibitor 1 RNA-binding protein	
Q8NC51	UniProtKB	Modified residue	25	25	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:19690332,PMID:23186163,PMID:24275569	
Q8NC51	UniProtKB	Modified residue	52	52	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9CY58	
Q8NC51	UniProtKB	Modified residue	68	68	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8NC51	UniProtKB	Modified residue	122	122	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8NC51	UniProtKB	Modified residue	140	140	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8NC51	UniProtKB	Modified residue	165	165	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9CY58	
Q8NC51	UniProtKB	Modified residue	188	188	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9CY58	
Q8NC51	UniProtKB	Modified residue	197	197	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6AXS5	
Q8NC51	UniProtKB	Modified residue	203	203	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NC51	UniProtKB	Modified residue	205	205	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NC51	UniProtKB	Modified residue	208	208	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NC51	UniProtKB	Modified residue	211	211	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8NC51	UniProtKB	Modified residue	216	216	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8NC51	UniProtKB	Modified residue	221	221	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NC51	UniProtKB	Modified residue	234	234	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:23186163	
Q8NC51	UniProtKB	Modified residue	329	329	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9CY58	
Q8NC51	UniProtKB	Modified residue	330	330	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:23186163,PMID:24275569	
Q8NC51	UniProtKB	Modified residue	364	364	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8NC51	UniProtKB	Modified residue	367	367	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8NC51	UniProtKB	Modified residue	370	370	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8NC51	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:23186163	
Q8NC51	UniProtKB	Modified residue	394	394	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:24275569	
Q8NC51	UniProtKB	Cross-link	52	52	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
Q8NC51	UniProtKB	Cross-link	102	102	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28695742;Dbxref=PMID:28695742	
Q8NC51	UniProtKB	Cross-link	102	102	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q8NC51	UniProtKB	Cross-link	211	211	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8NC51	UniProtKB	Cross-link	228	228	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:25114211,ECO:0000269|PubMed:28695742;Dbxref=PMID:25114211,PMID:28695742	
Q8NC51	UniProtKB	Cross-link	228	228	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25755297,PMID:25772364,PMID:28112733	
Q8NC51	UniProtKB	Cross-link	281	281	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28695742;Dbxref=PMID:28695742	
Q8NC51	UniProtKB	Cross-link	281	281	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q8NC51	UniProtKB	Alternative sequence	203	208	.	.	.	ID=VSP_011630;Note=In isoform 2 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11230166,ECO:0000303|PubMed:15489334,ECO:0000303|Ref.4;Dbxref=PMID:11230166,PMID:15489334	
Q8NC51	UniProtKB	Alternative sequence	233	247	.	.	.	ID=VSP_011631;Note=In isoform 3 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:10810093,ECO:0000303|PubMed:11230166,ECO:0000303|PubMed:15489334,ECO:0000303|Ref.4,ECO:0000303|Ref.9;Dbxref=PMID:10810093,PMID:11230166,PMID:15489334	
Q8NC51	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Not sumoylated%3B when associated with R-228 and R-281. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28695742;Dbxref=PMID:28695742	
Q8NC51	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Not sumoylated%3B when associated with R-102 and R-281. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28695742;Dbxref=PMID:28695742	
Q8NC51	UniProtKB	Mutagenesis	281	281	.	.	.	Note=Not sumoylated%3B when associated with R-102 and R-228. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28695742;Dbxref=PMID:28695742	
Q8NC51	UniProtKB	Sequence conflict	55	55	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NC51	UniProtKB	Sequence conflict	101	101	.	.	.	Note=L->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NC51	UniProtKB	Sequence conflict	312	312	.	.	.	Note=N->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NC51	UniProtKB	Sequence conflict	376	376	.	.	.	Note=R->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
